Skip to main content

Table 1 Lipid and apolipoprotein parameters in non-CAD and CAD subjects

From: Identification of the HDL-ApoCIII to VLDL-ApoCIII ratio as a predictor of coronary artery disease in the general population: The Chin-Shan Community Cardiovascular Cohort (CCCC) study in Taiwan

 

Non-CAD (N=200)

CAD (N=90)

P value

Men, %

48.0

80.0

0.01

Age, yr

53.4±10.7

57.4±10.9

0.233

Parameters (mg/dL±SEM)

   

 TG

223.2±15.8

261.9±12.4

0.07

 TC

224.3±4.3

244.8±7.0

0.01

 HDL-C

42.5±0.8

37.0±1.2

0.0003

 LDL-C

165.5±4.1

174.6±6.7

0.23

 ApoAI

130.4±2.3

77.8±5.7

<0.0001

 ApoB

97.9±7.8

111.7±3.1

0.10

 Lp(a)

1.3±0.1

1.1±0.2

0.36

 ApoCIII

18.9±0.4

17.4±0.6

0.06

 HDL-ApoCIII

9.4±0.2

12.3±0.4

<0.0001

 VLDL-ApoCIII

9.9±0.3

5.5±0.4

<0.0001

 ApoE

4.2±0.1

5.0±0.3

0.05

 VLDL-ApoE

1.3±0.1

1.7±0.3

0.18

 HDL-ApoE

3.0±0.1

3.4±0.2

0.07

  1. Data are expressed as the mean ± standard error of the mean (SEM)
  2. CAD = coronary artery disease; TG = triglyceride; TC = total cholesterol; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; Apo = apolipoprotein; Lp(a) = lipoprotein (a); HDL = high-density lipoprotein; VLDL = very-low-density lipoprotein.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X